AS50510
Cancer Research UK — ncuk.net
Summary
| Country |
 United Kingdom
|
| Organization | Cancer Research UK |
| Domain | ncuk.net |
| Number of IPv4 | 9,728 |
| Number of IPv6 | 0 |
| AS Type | Business |
| Registry | RIPE NCC |
| Allocated | February 01, 2010 (about 15 years ago) |
| Updated | September 04, 2018 (about 6 years ago) |
IP Ranges
AS50510 announces 7 IPv4 ranges and 0 IPv6 range.
That's a total of 9,728 IPv4 address and 0 IPv6 address.
| Prefix | Organization | Size | Registry | Status |
|---|---|---|---|---|
| 143.65.192.0/19 |
CRUK-NET
|
8,192 | RIPE NCC | LEGACY |
| 143.65.192.0/24 |
CRUK-NET
|
256 | RIPE NCC | LEGACY |
| 143.65.196.0/24 |
CRUK-NET
|
256 | RIPE NCC | LEGACY |
| 143.65.200.0/24 |
CRUK-NET
|
256 | RIPE NCC | LEGACY |
| 143.65.201.0/24 |
CRUK-NET
|
256 | RIPE NCC | LEGACY |
| 143.65.202.0/24 |
CRUK-NET
|
256 | RIPE NCC | LEGACY |
| 143.65.206.0/24 |
CRUK-NET
|
256 | RIPE NCC | LEGACY |
Peers
AS50510 does not have any direct peering agreements. Instead, its global connectivity is achieved through transit providers. While this setup ensures comprehensive reach, future peering could reduce latency and optimize route efficiency.
Upstreams
AS50510 connects to the global Internet via at least 2 upstream providers. In this setup, AS50510 acts as a customer, subscribing to these transit services to obtain full BGP routing information and ensure reliable, redundant access to external networks.
Downstreams
AS50510 currently has no downstream networks, meaning it does not serve as a transit provider to customer networks.